Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.46 EUR | -0.36% | -0.36% | -2.06% |
May. 09 | Mib bearish; focus on quarterly reports and BoE | AN |
May. 08 | Milan lone in red; Leonardo tops Mib | AN |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- The company is in debt and has limited leeway for investment
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-2.06% | 1.03B | B | ||
+9.48% | 27.43B | B+ | ||
-28.65% | 3.18B | B- | ||
-16.08% | 2.53B | C+ | ||
+19.05% | 2.49B | - | A- | |
+11.11% | 2.16B | B | ||
-4.24% | 2.03B | - | ||
+5.56% | 1.61B | B | ||
+1.69% | 1.31B | - | ||
+29.73% | 1.29B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- GVS Stock
- Ratings GVS S.p.A.